Neuronetics Inc
STIM2.520USD
-0.220-8.03%
終値 11/06, 16:00（ET）15分遅れの株価
172.48M時価総額
損失額直近12ヶ月PER
詳細情報 Neuronetics Inc 企業名
Neuronetics, Inc. is a medical technology company focused on designing, developing, and marketing products for patients who suffer from neurohealth disorders. Its NeuroStar Advanced Therapy for Mental Health is a non-drug, noninvasive treatment for people suffering from neurohealth conditions. In addition to selling the NeuroStar system and associated treatment sessions to customers, it operates treatment centers across the United States, offering both NeuroStar Advanced Therapy (transcranial magnetic stimulation or TMS) and Spravato (esketamine nasal spray) for the treatment of major depressive disorder (MDD) and other mental health disorders. NeuroStar Advanced Therapy is the TMS treatment for MDD in adults. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. It provides more than 1.68 million treatments to over 51,000 patients struggling with depression.
Neuronetics Incの企業情報
企業コードSTIM
会社名Neuronetics Inc
上場日Jun 28, 2018
最高経営責任者「CEO」Mr. Keith J. Sullivan
従業員数716
証券種類Ordinary Share
決算期末Jun 28
本社所在地3222 Phoenixville Pike
都市MALVERN
証券取引所NASDAQ Global Market Consolidated
国United States of America
郵便番号19355
電話番号18776007555
ウェブサイトhttps://neurostar.com/neuronetics/
企業コードSTIM
上場日Jun 28, 2018
最高経営責任者「CEO」Mr. Keith J. Sullivan
Neuronetics Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Sasha Cucuz
Mr. Sasha Cucuz
Director
Director
2.03M
+0.32%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
588.77K
+1.82%
Mr. Steven Pfanstiel
Mr. Steven Pfanstiel
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
400.00K
--
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
335.45K
+2.30%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
185.35K
+4.12%
Ms. Megan Rosengarten
Ms. Megan Rosengarten
Independent Director
Independent Director
140.89K
+27.05%
Mr. W. Andrew Macan
Mr. W. Andrew Macan
Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
--
--
Dr. Avinash N. Amin, M.D.
Dr. Avinash N. Amin, M.D.
Director
Director
--
--
Mr. Mark Klausner
Mr. Mark Klausner
Managing Partner
Managing Partner
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Sasha Cucuz
Mr. Sasha Cucuz
Director
Director
2.03M
+0.32%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
588.77K
+1.82%
Mr. Steven Pfanstiel
Mr. Steven Pfanstiel
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
400.00K
--
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
335.45K
+2.30%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
185.35K
+4.12%
Ms. Megan Rosengarten
Ms. Megan Rosengarten
Independent Director
Independent Director
140.89K
+27.05%
収益内訳
通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Clinic revenue
23.02M
60.42%
Treatment sessions
11.05M
29.00%
NeuroStar Advanced Therapy System
3.65M
9.57%
Other
385.00K
1.01%
地域別USD
会社名
収益
比率
United States
37.66M
98.81%
International
452.00K
1.19%
事業別
地域別
事業別USD
会社名
収益
比率
Clinic revenue
23.02M
60.42%
Treatment sessions
11.05M
29.00%
NeuroStar Advanced Therapy System
3.65M
9.57%
Other
385.00K
1.01%
株主
更新時刻: Sat, Aug 23
更新時刻: Sat, Aug 23
株主統計
種類
株主統計
株主統計
比率
Madryn Asset Management, LP
30.28%
The Vanguard Group, Inc.
4.00%
BlackRock Institutional Trust Company, N.A.
2.99%
Cucuz (Sasha)
2.97%
Sullivan (Keith J)
2.35%
他の
57.41%
株主統計
株主統計
比率
Madryn Asset Management, LP
30.28%
The Vanguard Group, Inc.
4.00%
BlackRock Institutional Trust Company, N.A.
2.99%
Cucuz (Sasha)
2.97%
Sullivan (Keith J)
2.35%
他の
57.41%
種類
株主統計
比率
Private Equity
31.36%
Hedge Fund
10.96%
Investment Advisor
9.91%
Individual Investor
9.48%
Investment Advisor/Hedge Fund
4.83%
Research Firm
1.83%
Bank and Trust
0.10%
Pension Fund
0.07%
他の
31.47%
機関投資家保有株
更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
196
39.02M
59.02%
-13.74M
2025Q2
187
47.56M
71.93%
-4.03M
2025Q1
191
47.19M
71.70%
-4.84M
2024Q4
155
36.70M
70.38%
+11.74M
2024Q3
153
14.58M
47.42%
-9.85M
2024Q2
159
20.22M
66.61%
-5.87M
2024Q1
183
20.38M
68.24%
-3.49M
2023Q4
191
18.37M
63.28%
-7.87M
2023Q3
201
19.69M
68.24%
-8.69M
2023Q2
222
21.10M
73.37%
-11.20M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Madryn Asset Management, LP
20.74M
31.36%
-3.50M
-14.44%
Aug 08, 2025
The Vanguard Group, Inc.
2.74M
4.15%
+436.54K
+18.93%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.05M
3.1%
+1.67M
+440.36%
Jun 30, 2025
Cucuz (Sasha)
2.02M
3.06%
+30.00K
+1.50%
May 22, 2025
Sullivan (Keith J)
1.61M
2.43%
--
--
Mar 24, 2025
Balyasny Asset Management LP
1.51M
2.28%
+92.05K
+6.50%
Jun 30, 2025
Ikarian Capital LLC
1.10M
1.66%
-300.00
-0.03%
Jun 30, 2025
Masters Capital Management, L.L.C.
1.00M
1.51%
--
--
Jun 30, 2025
Manatuck Hill Partners, LLC
920.00K
1.39%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
879.04K
1.33%
+556.27K
+172.34%
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: 21 hours ago
更新時刻: 21 hours ago
銘柄名
比率
AdvisorShares Psychedelics ETF
3.78%
Invesco NASDAQ Future Gen 200 ETF
0.4%
iShares Neuroscience and Healthcare ETF
0.2%
Vanguard US Momentum Factor ETF
0.06%
iShares Micro-Cap ETF
0.02%
iShares Russell 2000 Growth ETF
0.01%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.01%
Avantis US Small Cap Equity ETF
0%
ProShares Hedge Replication ETF
0%
Proshares Ultra Russell 2000
0%
詳細を見る
AdvisorShares Psychedelics ETF
比率3.78%
Invesco NASDAQ Future Gen 200 ETF
比率0.4%
iShares Neuroscience and Healthcare ETF
比率0.2%
Vanguard US Momentum Factor ETF
比率0.06%
iShares Micro-Cap ETF
比率0.02%
iShares Russell 2000 Growth ETF
比率0.01%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
比率0.01%
Avantis US Small Cap Equity ETF
比率0%
ProShares Hedge Replication ETF
比率0%
Proshares Ultra Russell 2000
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
